| Abstrakt: |
A recent study conducted at Boston Medical Center has highlighted significant advances in the identification, diagnosis, assessment, and management of infants with prenatal opioid exposure and neonatal opioid withdrawal syndrome (NOWS). The study aims to inform the clinical management of opioid-exposed newborns and provide an overview of NOWS care to promote best practices. The research reviews advances in the clinical diagnosis of NOWS, assessment strategies, nonpharmacologic and pharmacologic treatment modalities, factors associated with NOWS severity, and recommendations for postdelivery hospitalization follow-up and developmental surveillance. The study emphasizes the need for ongoing research to support the well-being of families impacted by opioid use. [Extracted from the article] |
